Depression of cytochrome P-450-dependent drug biotransformation by adriamycin

Deborah J. Marchand, Kenneth W. Renton

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

31 Citas (Scopus)

Resumen

The cytochrome P-450-dependent mixed function oxidase system was depressed following the administration of adriamycin. Cytochrome P-450, aminopyrine N-demethylase, and benzo(a)pyrene hydroxylase were significantly decreased in hepatic microsomes prepared from rats treated with a single dose of adriamycin (10 mg/kg subcutaneously) 4 days previously. Total microsomal protein levels and cytochrome b5 levels remained unchanged. The administration of cysteamine 1 hr prior to adriamycin prevented the loss of the cytochrome P-450 and the decrease in drug biotransformation. The administration of diethylmaleate had no effect on the ability of adriamycin to decrease this enzyme system. The loss of drug biotransformation and the protection offered by cysteamine is correlated with the lipid peroxidation activity in hepatic microsomes. This suggests that the loss of cytochrome P-450 and related drug biotransformation is related to the generation of free radicals and subsequent lipid peroxidation in the liver.

Idioma originalEnglish
Páginas (desde-hasta)83-88
Número de páginas6
PublicaciónToxicology and Applied Pharmacology
Volumen58
N.º1
DOI
EstadoPublished - mar. 30 1981

Nota bibliográfica

Funding Information:
’ This work was supported by a grant from the Medical Research Council of Canada. 2 Recipient of a studentship from Faculty of Graduate Studies, Dalhousie University. 3 Scholar of the Medical Research Council of Canada.

ASJC Scopus Subject Areas

  • Toxicology
  • Pharmacology

Huella

Profundice en los temas de investigación de 'Depression of cytochrome P-450-dependent drug biotransformation by adriamycin'. En conjunto forman una huella única.

Citar esto